Gilenya 0.5 mg hard capsules, Gilenya 0.25 mg hard capsules
CFTY720D2311
Phase 3 small_molecule active
Quick answer
Gilenya 0.5 mg hard capsules, Gilenya 0.25 mg hard capsules for Multiple Sclerosis is a Phase 3 program (small_molecule) at Novartis Ophthalmics Europe with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Novartis Ophthalmics Europe
- Indication
- Multiple Sclerosis
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active